Secondary hypertension
243 results
1 - 100Secondary hypertension
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults
Useful history, physical, and laboratory findings for predicting secondary hypertension in children and adolescents
Fewer than 4% of children with newly diagnosed hypertension in primary care or school settings have secondary causes
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases
Hypertension: investigations, treatment initiation and non-pharmacological treatment
Hypertension in children
Intracerebral haemorrhage
Phosphodiesterase 5 inhibitors for pulmonary hypertension
Cushing's syndrome
Drug treatment for hypertension
Intracranial aneurysm and subarachnoid haemorrhage (SAH)
Prostacyclin for pulmonary hypertension in adults
Phosphodiesterase 5 inhibitors for pulmonary hypertension: Cochrane systematic review
Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
Roselle for hypertension in adults
Antihypertensive therapy beneficial for patients with BP < 140/90 and history of CVD
Hypertension treatment effective even after age 80
Angiotensin receptor blockers or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation
Treatment of mild chronic hypertension during pregnancy is beneficial
Hydralazine for essential hypertension
Spironolactone for hypertension: Cochrane systematic review
Bariatric surgery in obese patients with hypertension can produce normotension in some of them (GATEWAY)
Venous insufficiency of the lower limbs
First‐line drugs for hypertension
Phosphodiesterase 5 inhibitors for pulmonary hypertension
Antiplatelet agents and anticoagulants for hypertension
Weak evidence that optimal neonatal outcomes are associated with delivery at 39 weeks for pregnant individuals with mild chronic hypertension
Raynaud's phenomenon (RP) or white finger disease
Methyldopa for primary hypertension: Cochrane systematic review
Beta-blockers for preventing stroke recurrence: Cochrane systematic review
Hypokalaemia
Renin inhibitors versus angiotensin receptor blockers for primary hypertension
Inhaled iloprost for pulmonary hypertension
Cesarean rates and neonatal outcomes similar with induction vs expectant management with unripe cervix
Headache
Guided imagery for treating hypertension in pregnancy
Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension
Riociguat for pulmonary hypertension
ASA for hypertension
Pharmacotherapy for hypertension in adults 60 years or older
IgA nephropathy
Pharmacotherapy for mild hypertension
Eplerenone for hypertension
Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus: Cochrane systematic review
Long‐term effects of weight‐reducing diets in people with hypertension
Cerebral infarction (ischaemic stroke)
Guanylate cyclase stimulators for pulmonary hypertension
Interventions for altering blood pressure in people with acute subarachnoid haemorrhage
Glomerulonephrites
Treatment of hypertension in peripheral arterial disease
Different types of dietary advice for women with gestational diabetes mellitus
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Higher BP target does not reduce mortality in septic patients (SEPSISPAM)
Proteinuria
Blood pressure targets in adults with hypertension
Long‐term effects of weight‐reducing drugs in people with hypertension
ACE = ARB for secondary CV prevention; combination worse (ONTARGET)
Prostacyclin for pulmonary hypertension
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
No difference in major vascular complications with different blood pressure strategies after noncardiac surgery (POISE-3)
Calcium channel blockers versus other classes of drugs for hypertension
Evening versus morning dosing regimen drug therapy for hypertension
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease